Focus: Veeva Systems is a cloud-based software and services company serving the pharmaceutical and life sciences industry, with ~$2.4B in FY2026 revenue and 5,001-10,000 employees globally. It is the dominant provider of clinical trial management, regulatory intelligence, and commercial engagement platforms for pharma.
Profile data last refreshed 6h ago · AI intelligence enriched 3w ago
No open roles listed right now. Follow Veeva Systems to get notified when they start hiring — the background below is worth knowing for when they do.
Core platform driving recurring SaaS revenue for pharmaceutical regulatory and clinical operations globally.
Help build intelligence for Veeva Systems
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Veeva Systems's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Primary sales and marketing execution platform for pharmaceutical brand engagement and rep productivity.
Recently acquired ($100M, March 2026) to enhance AI-driven pharma engagement capabilities and competitive differentiation.
Veeva Systems : The Industry Cloud for Life Sciences Amid AI Revolution and CRM Evolution - TradingView
Veeva Systems : The Industry Cloud for Life Sciences Amid AI Revolution and CRM Evolution TradingView
Reasons to Consider Including Veeva Systems Shares in Your Portfolio at This Time - Bitget
Reasons to Consider Including Veeva Systems Shares in Your Portfolio at This Time Bitget
Reasons to Consider Including Veeva Systems Shares in Your Portfolio at This Time - Bitget
Reasons to Consider Including Veeva Systems Shares in Your Portfolio at This Time Bitget
Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement - Fierce Pharma
Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement Fierce Pharma
5 Revealing Analyst Questions From Veeva Systems’s Q4 Earnings Call - The Globe and Mail
5 Revealing Analyst Questions From Veeva Systems’s Q4 Earnings Call The Globe and Mail
Veeva Systems Q4 Earnings Beat Forecasts on Strong Pharma Demand - News and Statistics - IndexBox
Veeva Systems Q4 Earnings Beat Forecasts on Strong Pharma Demand - News and Statistics IndexBox
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo